1. Home
  2. REVB vs ATXG Comparison

REVB vs ATXG Comparison

Compare REVB & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$1.28

Market Cap

5.1M

Sector

Health Care

ML Signal

N/A

ATXG

Addentax Group Corp.

N/A

Current Price

$0.26

Market Cap

4.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
REVB
ATXG
Founded
2020
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REVB
ATXG
Price
$1.28
$0.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.5K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.26
52 Week High
$3.73
$1.86

Technical Indicators

Market Signals
Indicator
REVB
ATXG
Relative Strength Index (RSI) 47.54 28.82
Support Level $0.77 N/A
Resistance Level $1.38 $0.49
Average True Range (ATR) 0.09 0.03
MACD -0.03 -0.01
Stochastic Oscillator 31.03 4.12

Price Performance

Historical Comparison
REVB
ATXG

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: